HIV/AIDS Therapy

Once-daily quadruple regimen safe, effective

Published in AIDS Weekly, October 7th, 2002

by Michael Greer, senior medical writer - A once-daily regimen combining four antiretroviral agents in safe and effective, researchers in the United States report.

Gail Skowron and colleagues at Roger Williams Medical Center in Providence, Rhode Island, the University of Colorado in Denver, the AIDS Research Consortium of Atlanta, the University of Alabama in Birmingham, GlaxoSmithKline in Research Triangle Park, North Carolina, Bristol-Myers Squibb in Plainsboro, New Jersey, and Gilead Sciences in Foster City, California assessed the benefits of once-daily treatment with adefovir dipivoxil, lamivudine, didanosine, and efavirenz.

This regimen...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2002-10-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry